Birznieks Gunther

CIK 00017020311 companyWASHINGTON, DC

SEC Profile

Transactions

Companies

Filings

CIK

0001702031

Recent Transactions

35 trades

Tax Payment
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-03-01$4.76/sh−26,941→ 411,628 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2025-02-18+125,000→ 438,569 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-03-05$4.13/sh−8,684→ 313,569 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-03-04$4.30/sh−8,727→ 322,253 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2024-02-16+125,000→ 330,980 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-03-03$6.26/sh−8,268→ 205,980 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-03-02$6.20/sh−8,509→ 214,248 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2023-02-16+32,700→ 222,757 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2023-02-16+77,500→ 77,500 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-08-26$3.12/sh+1,250→ 190,057 total
Exercise/Conversion
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2022-08-26−1,250→ 0 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-03-02$11.27/sh−11,517→ 188,807 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-03-01$11.19/sh−4,084→ 200,324 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2022-02-28+32,700→ 204,408 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Stock Option (Right to Buy)
2022-02-28+77,500→ 77,500 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-02$18.19/sh−16,620→ 171,708 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-03-01$18.66/sh−3,845→ 188,328 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2021-02-24+77,500→ 77,500 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2021-02-24+32,700→ 192,173 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-03-03$10.66/sh−5,535→ 159,473 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-03-02$10.04/sh−12,223→ 165,008 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-02-26+30,000→ 177,231 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2020-02-26+70,000→ 70,000 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2020-01-02$15.93/sh−4,020→ 147,231 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-03-04$19.89/sh−8,788→ 151,251 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-03-01$20.14/sh−3,741→ 160,039 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-02-27+30,000→ 163,780 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2019-02-27+70,000→ 70,000 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-03$26.09/sh−1,619→ 133,780 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-02$26.30/sh−3,272→ 136,569 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2019-01-02$26.95/sh−1,170→ 135,399 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-03-01$18.72/sh−8,525→ 139,841 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Employee Stock Option (Right to Buy)
2018-02-28+70,000→ 70,000 total
Award
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-02-28+30,000→ 148,366 total
Sale
Vanda Pharmaceuticals Inc.$VNDA
Common Stock
2018-01-02$15.26/sh−8,568→ 118,366 total

Companies

Vanda Pharmaceuticals Inc.
SVP, Business Development
$VNDA

Recent Filings

Address

2200 PENNSYLVANIA AVENUE NW SUITE 300E

WASHINGTON, DC, 20037

View on SEC.gov